Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 16024755)

1.
2.

Mitochondria play a central role in estrogen-induced neuroprotection.

Simpkins JW, Wang J, Wang X, Perez E, Prokai L, Dykens JA.

Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):69-83. Review.

PMID:
15723615
3.

Mitochondrial mechanisms of estrogen neuroprotection.

Simpkins JW, Dykens JA.

Brain Res Rev. 2008 Mar;57(2):421-30. Epub 2007 Apr 27. Review.

PMID:
17512984
6.

Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds.

Behl C, Moosmann B.

Biol Chem. 2002 Mar-Apr;383(3-4):521-36. Review.

PMID:
12033440
7.

Estrogen and non-feminizing estrogen for Alzheimer's disease.

Honjo H, Iwasa K, Fushiki S, Hosoda T, Tatsumi H, Mihara M, Hirasugi Y, Oida M, Kariya K, Kikuchi N, Kawata M.

Endocr J. 2003 Aug;50(4):361-7. Review.

8.
9.

17beta-estradiol does not protect cerebellar granule cells from excitotoxicity or apoptosis.

Miñano A, Cerbón MA, Xifró X, Malagelada C, Aguilera J, Rodríguez-Alvarez J.

J Neurochem. 2007 Jul;102(2):354-64.

PMID:
17596211
10.
11.
12.

Neuroprotective effects of 17beta-estradiol and nonfeminizing estrogens against H2O2 toxicity in human neuroblastoma SK-N-SH cells.

Wang X, Dykens JA, Perez E, Liu R, Yang S, Covey DF, Simpkins JW.

Mol Pharmacol. 2006 Jul;70(1):395-404. Epub 2006 Apr 13.

13.

Equine estrogens differentially prevent neuronal cell death induced by glutamate.

Bhavnani BR, Berco M, Binkley J.

J Soc Gynecol Investig. 2003 Jul;10(5):302-8.

PMID:
12853093
14.

17beta-estradiol protects SH-SY5Y Cells against HIV-1 gp120-induced cell death: evidence for a role of estrogen receptors.

Russo R, Navarra M, Maiuolo J, Rotiroti D, Bagetta G, Corasaniti MT.

Neurotoxicology. 2005 Oct;26(5):905-13.

PMID:
15899520
15.

Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.

Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J.

J Neurosci Res. 2008 Dec;86(16):3622-34. doi: 10.1002/jnr.21805.

PMID:
18709653
16.

During development, 17alpha-estradiol is a potent estrogen and carcinogen.

Hajek RA, Robertson AD, Johnston DA, Van NT, Tcholakian RK, Wagner LA, Conti CJ, Meistrich ML, Contreras N, Edwards CL, Jones LA.

Environ Health Perspect. 1997 Apr;105 Suppl 3:577-81.

17.

Neuroprotective effects of estrogens: potential mechanisms of action.

Green PS, Simpkins JW.

Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):347-58. Review.

PMID:
10817919
18.

17Beta-estradiol reduces nitrotyrosine immunoreactivity and increases SOD1 and SOD2 immunoreactivity in nigral neurons in male mice following MPTP insult.

Tripanichkul W, Sripanichkulchai K, Duce JA, Finkelstein DI.

Brain Res. 2007 Aug 20;1164:24-31. Epub 2007 Jun 23.

PMID:
17640623
19.

Mitochondria as therapeutic targets of estrogen action in the central nervous system.

Nilsen J, Brinton RD.

Curr Drug Targets CNS Neurol Disord. 2004 Aug;3(4):297-313. Review.

PMID:
15379606
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk